Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065904
Filing Date
2015-11-16
Accepted
2015-11-16 15:29:32
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423531_10q.htm 10-Q 630892
2 EXHIBIT 10.1 v423531_ex10-1.htm EX-10.1 47636
3 EXHIBIT 10.2 v423531_ex10-2.htm EX-10.2 140383
4 EXHIBIT 10.3 v423531_ex10-3.htm EX-10.3 280177
5 EXHIBIT 10.4 v423531_ex10-4.htm EX-10.4 111774
6 EXHIBIT 10.5 v423531_ex10-5.htm EX-10.5 79133
7 EXHIBIT 31.1 v423531_ex31-1.htm EX-31.1 9453
8 EXHIBIT 32.1 v423531_ex32-1.htm EX-32.1 4498
  Complete submission text file 0001144204-15-065904.txt   8128945

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT prgb-20150930.xml EX-101.INS 1736346
10 XBRL TAXONOMY EXTENSION SCHEMA prgb-20150930.xsd EX-101.SCH 77505
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prgb-20150930_cal.xml EX-101.CAL 50336
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgb-20150930_def.xml EX-101.DEF 489642
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgb-20150930_lab.xml EX-101.LAB 543471
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgb-20150930_pre.xml EX-101.PRE 548259
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26505
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 151233893
SIC: 2834 Pharmaceutical Preparations